A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace

Epidemiology and Treatment of Multidrug-resistant (MDR TB) and Extensively Drug- Resistant (XDR TB) Tuberculosis in Strasbourg, France; a 10 Years Retrospective Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03507816

Enrollment

Registered

2018-04-25

Start date

2018-02-23

Completion date

2020-02-29

Last updated

2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

Tuberculosis, Multi-drug Resistant Tuberculosis, Observational retrospective study, Clinical epidemiology, Treatment outcome, Migrant, Precarity

Brief summary

The purpose of this study is to examine the epidemiology of TB MR in Strasbourg and evaluate the second-line anti-tuberculosis treatments effectiveness, and the relevance and adequacy of the treatments with WHO recommendations. During years 2006-2016, all new cases of MDR TB or XDR TB diagnosed Strasbourg University Hospital will be included in the study (22 cases). Data were collected from the Center for Tuberculosis Control (CLAT) records, the patient's medical records.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Major patient (≥18 years old) * Patient hospitalized at Strasbourg University Hospital from 2006 to 2016, with proven MDR or XDR tuberculosis

Exclusion criteria

\- Refusal of the patient to participate in the study

Design outcomes

Primary

Measure	Time frame
Study of clinical characteristics of patients hospitalized at Strasbourg University Hospital from 2006 to 2016, with proven MDR or XDR tuberculosis	The period from January 1st, 2006 to December 31st, 2016 will be examined

Countries

France

Contacts

Primary ContactXavier ARGEMI, MD

xavier.argemi@chru-strasbourg.fr33 3 69 55 11 87

Backup ContactMagalie Paz, MD

magalie.paz@chru-strasbourg.fr33 3 69 55 11 87

Outcome results